US pharmaceuticals major Pfizer is considering moving some of its
activities in Germany to the UK due to government health reforms;
meanwhile, Merck & Co has shelved plans to open a new R&D
facility in the country.
Australian packaging group Amcor has entered into a A$330 million
(€198m) agreement to buy Rexam's healthcare flexibles packaging
business and will also buy out Danisco and Ahlstrom's 28.1 per cent
minority stake in its...
US e-business software company Fugensoft has revamped its product
range, introducing a suite of new products and a change of focus,
to meet the needs of the biotech and pharmaceutical industry 'where
there is a huge need for...
Top pharmaceutical manufacturing plants strive to achieve efficient
operations that result in increased profitability as well as
superior product quality and satisfied customers. These are the
findings of a new study from market research...
US biopharmaceutical company Aastrom Biosciences has received
approval to market and sell its DCV-II cancer vaccine production
kits in the European Union. The company believes the market will
offer a new potential path to near-term...